Barriers to biosimilar utilization in the United States-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Barriers to biosimilar utilization in the United States

Published:2020-10-22 Issue:23 Volume:77 Page:2006-2014
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Dalpoas Stacy Elder¹,Socal Mariana²,Proctor Celia³,Shermock Kenneth M³

Affiliation:

1. Department of Pharmacy, Johns Hopkins Bayview Medical Center, Baltimore, MD

2. Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD

3. Department of Pharmacy, Johns Hopkins Health System, Baltimore, MD

Funder

Arnold Ventures

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/77/23/2006/34322370/zxaa297.pdf

Reference55 articles.

1. Biosimilars: primer for health-system pharmacists;Lucio;Am J Health-Syst Pharm,2013

2. The US biosimilar market: stunted growth and possible reforms;Sarpatwari;Clin Pharmacol Ther,2019

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biosimilars in the Era of Artificial Intelligence—International Regulations and the Use in Oncological Treatments;Pharmaceuticals;2024-07-10

2. Evaluation of a Quality Improvement Process for Health-System Retention of Long Acting Growth Factors Prescriptions in the Pediatric Oncology Population;The Journal of Pediatric Pharmacology and Therapeutics;2024-04-01

3. The Impact of Biosimilar Use on Total Cost of Care and Provider Financial Performance in the Medicare Oncology Care Model: A Population-Based Simulation Study;Advances in Therapy;2023-11-14

4. Biosimilars in Dermatology Review;Journal of Psoriasis and Psoriatic Arthritis;2023-11-03

5. Similar Growth Outcomes in Children with Inflammatory Bowel Disease Initiated on Infliximab Originator or Biosimilar;Journal of Pediatric Gastroenterology & Nutrition;2023-09-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3